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Background: Caveolin-3 (cav-3) mutations are linked to the long-QT syndrome (LQTS) causing distinct clinical
symptoms. Hyperpolarization-activated cyclic nucleotide channel 4 (HCN4) underlies the pacemaker current If.
It associates with cav-3 and both form a macromolecular complex. Methods: To examine the effects of human
LQTS-associated cav-3 mutations on HCN4-channel function, HEK293-cells were cotransfected with HCN4 and
wild-type (WT) cav-3 or a LQTS-associated cav-3 mutant (T78M, A85T, S141R, or F97C). HCN4 currents were
recorded using the whole-cell patch-clamp technique. Results: WT cav-3 signiﬁcantly decreased HCN4 current
density and shifted midpoint of activation into negative direction. HCN4 current properties were differentially
modulated by LQTS-associated cav-3 mutations. When compared with WT cav-3, A85T, F97C, and T78M did not
alter the speciﬁc effect of cav-3, but S141R signiﬁcantly increased HCN4 current density. Compared with WT cav-3,
no signiﬁcant modiﬁcations of voltage dependence of steady-state activation curves were observed. However, while
WT cav-3 alone had no signiﬁcant effect on HCN4 current activation, all LQTS-associated cav-3 mutations
signiﬁcantly accelerated HCN4 activation kinetics. Conclusions: Our results indicate that HCN4 channel function is
modulated by cav-3. LQTS-associated mutations of cav-3 differentially inﬂuence pacemaker current properties
indicating a pathophysiological role in clinical manifestations.
Keywords: long-QT syndrome, caveolin-3, hyperpolarization-activated cyclic nucleotide gated channel 4, If,
whole-cell current
Introduction
The congenital long-QT syndrome (LQTS) is a potentially fatal disease, which is character-
ized by delayed cardiac repolarization, prolonged QT interval, and ventricular tachyar-
rhythmias leading to sudden cardiac death. It is caused by mutations in several genes
encoding protein subunits of cardiac ion channels (28).
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Hyperpolarization-activated cyclic nucleotide channels (HCN) underlie the cardiac
pacemaker current If and play a central role in cardiac pacemaker activity (8). The HCN
family consists of four mammalian isoforms (HCN1–4) (7, 8, 18). Among them, HCN4 is
known to be the dominant isoform of the sinus node region, which is responsible for
spontaneous cardiac pacemaker activity (26).
Lipid rafts are microdomains of the plasma membranes, which consist of cholesterol and
sphingolipids (12). They are responsible for the coordination of multiple cellular processes
including second-messenger signaling and modulation of biophysical properties of ion
channels. Caveolae are the lipid rafts composed of caveolin. By recruiting lipids and proteins
that participate in intracellular trafﬁcking, signal transduction as well as endo- and exocytosis,
these scaffolding proteins are essential for the formation of caveolae complexes (2).
Cardiac sinus node cells contain a high density of caveolae (20). Furthermore, caveolae
are known to modulate sympathetic response to the heart by colocalization of cellular key
signaling molecules, such as G proteins, adenyl cyclase, and protein kinase A (25). A total of
3 members of the caveolin family are known to be essential for caveolae formation: caveolins
1, 2, and 3 (cav-1–3) (13). In cardiac tissue, caveolae formation depends on cav-3 (9), which
colocalizes with different cardiac ion channels (3, 19, 30). HCN4 is localized in calveolae and
was shown to interact with cav-3 proteins (4, 5). Furthermore, calveolae disruption was
proven to alter the gating function of HCN4 channels by shifting the voltage dependence of
activation into positive direction (4).
Several mutations in cav-3 have been identiﬁed to associate with the congenital LQTS,
namely, T78M, A85T, F97C, and S141R. In heterologous expression, these cav-3 mutations
increased the late sodium current. Each mutation leads to speciﬁc clinical symptoms, such as
sinus bradycardia and non-exertional syncope (T78M), cardiac arrest in sleep (A85T),
shortness of breath and chest pain (F97C), or non-exertional syncope (S141R) (29).
In this study, we investigated the effects of human wild-type (WT) cav-3 and LQTS-
associated cav-3 mutations on HCN4 ion channel function. We hypothesized cav-3 to
inﬂuence HCN4 current characteristics. Furthermore, if cav-3 mutations distinctively impair
electrophysiological HCN4 current properties, mutation-speciﬁc clinical manifestations
might be explained. Therefore, to investigate the effects of cav-3 or LQTS-associated
cav-3 mutations on HCN4 whole-cell current properties, we used heterologous expression
of cav-3 or LQTS-associated cav-3 mutations cotransfected with HCN4 in the HEK293 cell
system that naturally lacks cav-3 (25).
Materials and Methods
Plasmid construction
The expression plasmid pAdCGI-HCN4 (encoding the full-length sequences of HCN4 genes,
respectively) as well as pAdCGI have previously been described (7, 8, 15). The coding
sequence of red ﬂuorescent protein (RFP; pDsRed, Clontech, Saint-Germain-en-Laye, France)
was cloned into pAdCGI in place of the enhanced green ﬂuorescent protein (EGFP) sequence to
generate pAdCRI. The full-length coding sequence of human cav-3 was ampliﬁed by
polymerase chain reaction from human cardiac m-RNA, control sequenced, and cloned into
the multiple cloning site of pAdCRI to generate pAdCRI-CAV-3. Cav-3 mutations (T78M,
A85T, F97C, and S141R) were generated (11) using a QuickChange II XL Site-Directed
Mutagenesis Kit (Stragene, The Netherlands) as directed by the manufacturer (11).
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Transient transfections
Twenty-four hours before transfection, HEK293 cells (American Type Culture Collection,
Manassas, VA, USA) were seeded at a density of 2.0 × 105 cells/35-mm dish. The cells were
cotransfected with 0.25 μg/well plasmid DNA of HCN4 channels and 0.5 μg/well plasmid
DNA of cav-3, LQTS-associated cav-3 mutation, or an empty plasmid, as indicated, using
Lipofectamine Plus (Life Technologies, Gaithersburg, MD, USA), as directed by the
manufacturer. After 4 h, the transfection medium was replaced by normal growth medium.
The electrophysiological experiments were performed 48 h after the transfection.
Patch-clamp recordings in whole-cell conﬁguration
The experiments were carried out using standard microelectrode whole-cell patch-clamp
technique at room temperature (21–23 °C). The voltage error was compensated and currents
were recorded and digitized with an Axopatch 200B ampliﬁer and Digidata 1322 interface
(Molecular Devices, Sunnyvale, CA, USA) while being sampled at 10 kHz and ﬁltered at
2 kHz (7, 8, 14). The recording bath solution contained (in mmol/l) 135 NaCl, 5 KCl,
2 CaCl2, 1 MgCl2, 10 Glucose, and 10 HEPES; pH was adjusted to 7.4 with NaOH. The
pipette solution contained (in mmol/l) 130 K-glutamate, 5 KCl, 5 NaCl, 1 MgCl2, 10 HEPES,
and 5 Mg-ATP; pH was adjusted to 7.3 with KOH. Borosilicate microelectrodes had tip
resistances of 2–4 MΩ when ﬁlled with pipette solution.
Only traces with a good signal quality were analyzed in this study. HCN4 current size was
measured as the difference between the instantaneous current at the beginning of hyperpolar-
izing step ranging from −70 to −160 mV (or maximal −170 mV) in 10-mV decrements for
4.45–5 s, and the steady-state current at the end of hyperpolarization, as previously described
(7, 8, 14). Fast-current inactivation was achieved by a depolarization pulse to 20 mV. Since
most cells died when measurements at −170 mV were obtained, only traces recorded at
hyperpolarizing steps ranging from −70 to −160 mV were analyzed for this study. The current
density was calculated by the ratio of the measured current size relative to the cell capacitance
(pA/pF; mean cell capacitance: 46.37 ± 3.55 pF). For the calculation of voltage dependence of
steady-state activation curves, the speciﬁc current conductances (g) were normalized to the
maximal current conductance (gmax) to determine g/gmax. Boltzmann distributions were ﬁtted to
these normalized values as follows: g/gmax= 1/{1 + exp[(V1/2 − Vm)/S]}, where V1/2 is
the voltage at half-maximal activation, Vm is the membrane voltage, and S is a slope factor at
Vm= V1/2. To describe time constants for If activation (τ values), current traces were ﬁtted
ofﬂine to determine τ values for test potentials of −110 to −160 mV using Prism 5 (Graphpad,
San Diego, CA, USA) as previously described (7, 10). A xenon arc lamp was used to view
EGFP at 488-nm excitation/530-nm emission and RFP at 557-nm excitation/579-nm emission.
We observed no run-down phenomena during our recordings.
Statistical analysis
Pooled data are presented as mean ± standard error of the mean. Comparisons between
groups were performed with one-way ANOVA followed by post-hoc Tukey’s test. Proba-
bility values of p < 0.05 were regarded signiﬁcant.
Results
To evaluate the effect of cav-3 on HCN4 whole-cell currents, HEK293 cells were transiently
transfected with HCN4 in the presence of an empty control plasmid (CP) (to exclude non-speciﬁc
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effects), WT cav-3, or one of the LQTS-associated cav-3 mutations (T78M, A85T, F97C, or
S141R). The combination of cytosolic green and red ﬂuorescences veriﬁed effective cotransfec-
tion with both the plasmid-encoding HCN4 and the cav-3 construct, respectively.
Investigation of the LQTS-associated cav-3 mutations revealed differential modulations
of HCN4 currents, which are summarized in Table I.
Effects of cav-3 on HCN4 whole-cell current
Cav-3 signiﬁcantly decreased whole-cell current densities (Table I, Figs 1A, B and 2A) and
signiﬁcantly shifted the activation curve of IHCN4 to more negative values compared with
Table I. Whole-cell current parameters of HCN4+CP, HCN4+WT cav-3, HCN4+ cav-3 T78M, HCN4+ cav-3
A85T, HCN4+ cav-3 F97C, and HCN4+ cav-3 S141R
HCN4+ MCD (pA/pF) τ (ms) V½max (mV) n
WT cav-3 −6.30 ± 1.50 2,948 ± 354 −139.1 ± 4.0 11
CP −22.02 ± 2.66* 2,334 ± 382 −118.8 ± 5.0* 13
cav-3 T78M −5.89 ± 0.98 1,073 ± 271* −129.0 ± 1.9 13
cav-3 A85T −13.70 ± 2.43 1,056 ± 255* −130.1 ± 3.0 9
cav-3 F97C −13.23 ± 2.50 1,077 ± 434* −138.3 ± 2.8 7
cav-3 S141R −34.49 ± 6.35* 1,150 ± 60* −129.5 ± 2.9 7
MCD: mean current density at −130 mV; τ: time constant of activation at −130 mV; V½max: voltage of half maximal
activation.
*p < 0.05 vs. HCN4+WT cav-3
Fig. 1. Representative HCN4 whole-cell current recordings. HCN4 whole-cell current in the presence of (A) a CP,
(B) WT cav-3, (C) cav-3 T78M, (D) cav-3 A85T, (E) cav-3 F97C, or (F) cav-3 S141R. From a holding potential of
−40 mV, a hyperpolarization protocol by steps ranging from −70 to −160 mV in 10-mV decrements followed by a
depolarization step to 20 mV is presented
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transfection with CP (Table I, Fig. 2B). WT cav-3 had no signiﬁcant impact on τ values of
IHCN4 (Table I, Fig. 2C).
Effects of cav-3 LQTS-associated mutations on HCN4 whole-cell current
Compared with WT cav-3, the expression of cav-3 T78M, A85T, F97C, and S141R
mutations had no signiﬁcant impact on voltage dependence of steady-state activation curves
of IHCN4 (Table I, Fig. 3B). Furthermore, T78M, A85T, and F97C did not signiﬁcantly affect
the whole-cell current densities (Table I, Figs 1C–E and 3A). However, when matched to WT
cav-3, IHCN4 modulated by S141R presented signiﬁcantly increased whole-cell current
densities (Table I, Figs 1F and 3A). Of note, all four cav-3 LQTS-associated mutations
(T78M, A85T, F97C, and S141R) signiﬁcantly decreased τ values of IHCN4 indicating a faster
activation kinetic of IHCN4 (Table I, Fig. 3C).
Discussion
Our results conﬁrmed an interaction of HCN4 and cav-3. Importantly, compared with WT
cav-3, LQTS-associated cav-3 mutations were shown to differentially inﬂuence pacemaker
current properties (Table I).
Fig. 2. Effects of WT cav-3 on HCN4 whole-cell current properties. (A) Mean HCN4 current density measured as the
difference between the instantaneous current and steady-state current at the end of the hyperpolarization in the
presence of WT cav-3 (black) or a CP (gray). (B) Voltage dependence of steady-state activation curves of HCN4
currents. The voltage dependence of HCN4 calculated by Boltzmann ﬁts of normalized conductances (g/gmax) was
recorded in the presence ofWT cav-3 (black) or a CP (gray). (C) Time constant (τ) values of current activation plotted
as a function of test potentials in the presence of WT cav-3 (black) or a CP (gray)
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In this study, the expression of HCN4 and cav-3 in the HEK293 cell system, which
naturally lacks cav-3 (25), demonstrated a direct modulation of IHCN4 by cav-3. This resulted
in a signiﬁcant negative shift in the IHCN4 activation curve and a signiﬁcant decrease in IHCN4
whole-cell current density. Our observations are supported by previous ﬁndings. Importantly,
consistent with our data, disruption of caveolae in rabbit sinoatrial myocytes as well as human
embryonic stem cells resulted in a positive shift in the activation curve of If (4, 6).
Furthermore, cav-3 depletion was followed by an acceleration of spontaneous activity in
cardiomyocytes including the sinoatrial node cells (4, 9). Therefore, one might speculate that
cav-3 negatively regulates IHCN4 and probably If activity also.
HCN channels are responsible for the formation of the pacemaker current If (8, 18).
However, the expression of HCN isoforms in different systems gives rise to an inward
current with similar but not identical characteristics compared with the native pacemaker
current (7, 8). One of the reasons might be a modulation by β subunits in vivo. Indeed,
previous studies demonstrated the modulation of HCN channels by several β subunits,
which, interestingly similar to cav-3, are known to be associated with LQTS (1, 7, 16, 21).
Fig. 3. Effects of WT cav-3 and LQTS-associated cav-3 mutations on HCN4 whole-cell current properties.
(A) Mean HCN4 current density measured as the difference between the instantaneous current and steady-state
current at the end of the hyperpolarization in the presence of WT cav-3, cav-3 T78M, cav-3 A85T, cav-3 F97C,
or cav-3 S141R. (B) Voltage dependence of steady-state activation curves of HCN4 currents. The voltage
dependence of HCN4 calculated by Boltzmann ﬁts of normalized conductances (g/gmax) was recorded in the
presence of WT cav-3, cav-3 T78M, cav-3 A85T, cav-3 F97C, or cav-3 S141R. (C) Time constant (τ) values of
current activation plotted as a function of test potentials in the presence of WT cav-3, cav-3 T78M, cav-3 A85T,
cav-3 F97C, or cav-3 S141R
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Therefore, our data might suggest that, among others, cav-3 interacts with HCN4 to
modulate the channel’s activity and thus support the rise of the native pacemaker current
in vivo. Of note, HCN4 channels are the dominant isoform of the sinus node region (26),
which is primarily responsible for the spontaneous cardiac pacemaker activity. Indeed,
cav-3 and HCN4 were shown to associate in the pacemaker and the conduction system
of different species including human (4, 6, 22). Therefore, one might speculate that
under physiological conditions, cav-3 suppresses IHCN4 activity leading to slower
heart rates. These speculations are further supported by studies of spontaneous activity
in cav-3-depleted cardiomyocytes including the sinoatrial node cells, as previously
mentioned (4, 9).
Furthermore, to explore potential generation of symptoms in patients with cav-
3-associated LQTS mutations, in this trial, their impact on IHCN4 function was investi-
gated. Cav-3 mutations, such as T78M, A85T, F97C, and S141R, differentially affected
gating parameters of IHCN4. However, compared with WT cav-3, A85T, F97C, and
T78M did not alter current densities, but S141R signiﬁcantly increased the current
density of IHCN4. Importantly, all cav-3 mutations signiﬁcantly accelerated activation
kinetics of HCN4. Therefore, our results might indicate that these mutations undermine
WT cav-3-mediated effects by probably increasing IHCN4 activity using a mutation-
speciﬁc mechanism.
These observations could not explain sinus bradycardia as observed in carriers of
T78M cav-3 mutation (29). However, one might speculate that by establishing a more
active IHCN4, LQTS-associated cav-3 mutations increase If function and therefore accelerate
the rate of spontaneous diastolic depolarization in the sinus node region. This might induce
an increase in heart rate leading to sinus tachycardia. Sinus tachycardia is known to provoke
symptoms like angina and shortness of breath, which indeed are associated with mutations
of cav-3 in F97C (29). Furthermore, in LQTS accelerations of heart rate are described to
provoke ventricular arrhythmias (24). Therefore, these events might contribute to the
generation of ventricular tachycardia in LQTS patients leading to non-exertional syncope
and cardiac arrest in sleep as well as angina, and shortness of breath (27), which are
observed in patients with S141R, T78M, A85T, and F97C cav-3 mutations, respectively
(29). In addition, one might speculate a further mechanism of how an increase in HCN4
current activity could contribute to the generation of spontaneous ventricular tachycardias
in LQTS patients. Besides atrial, also ventricular myocytes express a small amount of HCN
channels amog them HCN4 (26). Of note, increased IHCN4 activity in the ventricle was
shown to provoke ventricular automaticity resulting in ventricular arrhythmias like
ventricular tachycardia (17, 23). However, these suggestions were not the matter of
investigation in this study and required to be addressed in further trials.
In summary, we provide an evidence for a direct interaction of WT cav-3 and HCN4
indicating that WT cav-3 negatively modulates IHCN4. This observation might be important
for the formation of physiological pacemaker currents in vivo. Furthermore, we demonstrated
LQTS-associated cav-3 mutations to differentially modulate HCN4 channel function indi-
cating a pathophysiological role in clinical manifestations.
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